Ultragenyx Pharmaceutical... (RARE)
NASDAQ: RARE
· Real-Time Price · USD
36.84
-0.30 (-0.81%)
At close: Jun 23, 2025, 3:59 PM
37.47
1.72%
Pre-market: Jun 24, 2025, 07:45 AM EDT
-0.81% (1D)
Bid | 37 |
Market Cap | 3.48B |
Revenue (ttm) | 590.69M |
Net Income (ttm) | -549.58M |
EPS (ttm) | -5.83 |
PE Ratio (ttm) | -6.32 |
Forward PE | -11.13 |
Analyst | Buy |
Ask | 40 |
Volume | 579,140 |
Avg. Volume (20D) | 1,020,938 |
Open | 36.82 |
Previous Close | 37.14 |
Day's Range | 36.30 - 37.41 |
52-Week Range | 29.59 - 60.37 |
Beta | 0.24 |
About RARE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RARE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RARE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Ultragenyx Pharmaceutical Inc. is scheduled to release its earnings on Jul 31, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-4.68%
RARE stock has given up its prior gain. Ultragenyx...
Unlock content with
Pro Subscription
1 month ago
-4.68%
Ultragenyx Pharmaceutical shares are trading higher after the company reported better-than-expected Q1 EPS results.